ArticleJMIR formative research2025
The Impact of ChatGPT Exposure on User Interactions With a Motivational Interviewing Chatbot: Quasi-Experimental Study.
Article in JMIR formative research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The worldwide introduction of ChatGPT in November 2022 may have changed how its users perceive and interact with other chatbots. This possibility may confound the comparison of responses to pre-ChatGPT and post-ChatGPT iterations of pre-existing chatbots, in turn affecting the direction of their evolution. Before the release of ChatGPT, we created a therapeutic chatbot, MIBot, whose goal is to use motivational interviewing to guide smokers toward making the decision to quit smoking. We were concerned that measurements going forward would not be comparable to those in the past, impacting the evaluation of future changes to the chatbot. Objective: The aim of the study is to explore changes in how users interact with MIBot after the release of ChatGPT and examine the relationship between these changes and users' familiarity with ChatGPT. Methods: We compared user interactions with MIBot prior to ChatGPT's release and 6 months after the release. Participants (N=143) were recruited through a web-based platform in November of 2022, prior to the release of ChatGPT, to converse with MIBot, in an experiment we refer to as MIBot (version 5.2). In May 2023, a set of (n=129) different participants were recruited to interact with the same version of MIBot and asked additional questions about their familiarity with ChatGPT, in the experiment called MIBot (version 5.2A). We used the Mann-Whitney U test to compare metrics between cohorts and Spearman rank correlation to assess relationships between familiarity with ChatGPT and other metrics within the MIBot (version 5.2A) cohort. Results: In total, 83(64.3%) participants in the MIBot (version 5.2A) cohort had used ChatGPT, with 66 (51.2%) using it on a regular basis. Satisfaction with MIBot was significantly lower in the post-ChatGPT cohort (U=11,331.0; P=.001), driven by a decrease in perceived empathy as measured by the Average Consultation and Relational Empathy Measure (U=10,838.0; P=.01). Familiarity with ChatGPT was positively correlated with average response length (ρ=0.181; P=.04) and change in perceived importance of quitting smoking (ρ=0.296; P<.001). Conclusions: The widespread reach of ChatGPT has changed how users interact with MIBot. Post-ChatGPT users are less satisfied with MIBot overall, particularly in terms of perceived empathy. However, users with greater familiarity with ChatGPT provide longer responses and demonstrated a greater increase in their perceived importance of quitting smoking after a session with MIBot. These findings suggest the need for chatbot developers to adapt to evolving user expectations in the era of advanced generative artificial intelligence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.